Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2018JAMA OncologyOpen Access

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

DWDaniel WangYale University
Joe‐Elie Salem
Joe‐Elie SalemCross-Cutting CardiologyJCJustine V. CohenHarvard University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2018) studied this question.

synapsesocial.com/papers/69d6cb12a0177bf533ed90bbhttps://doi.org/10.1001/jamaoncol.2018.3923
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma2017 · 203 citations
  2. 2Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement2009 · 83,689 citations
  3. 3Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation2010 · 1,503 citations
  4. 4Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy2016 · 1,226 citations
  5. 5Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study2017 · 513 citations